Presentation Information

[28-09-am02S]KRAS inhibitor tolerant pancreatic cancer cells utilize glutamine metabolism for survival

○Hiroki Furukawa1, Taichi Oshima1, Kosei Ito1, Shigeki Aoki1 (1. Grad. Sch. Pharm. Sci., Chiba Univ.)